Summary
Clinical psychology and psychotherapy address some of the largest groups of mental health need. WHO estimates depression affects about 322 million people and anxiety disorders affect about 470 million 12. Demand is met unevenly. In England, most NHS Talking Therapies referrals began treatment within 6 weeks in the latest official release, but outcomes fell and some local services report very long waits 7810. In the United States, workforce projections point to persistent shortfalls among psychologists and counselors 34. The pack does not contain verified market size, revenue, private-sector or digital adoption data, so commercial sizing is not possible. Main risks are workforce supply, uneven local access and unverified outcome trends. The outlook depends on whether workforce capacity and access targets can be sustained, and most projections are status-quo forecasts rather than verified outcomes.
Key findings
-
1
Mental health conditions affect very large populations globally.
WHO reports about 322 million people with depression and about 470 million with anxiety disorders, making anxiety the most common mental disorder group. These are observed prevalence estimates, not market data.
Confidence: High -
2
England's NHS Talking Therapies met its 6-week access target in the latest official release.
In August, 89.7% of referrals finishing a course waited less than 6 weeks, above the 75% 6-week target. The January figure was 91.0%. These are national averages that may hide local variation.
Confidence: High -
3
Outcomes in England's talking therapies fell in the reported December figure.
NHS England reports that 66.9% of patients achieved reliable improvement in the reported month and that outcomes fell. The pack does not give the prior baseline, so the size of the decline cannot be assessed.
Confidence: Medium -
4
US workforce projections show a persistent psychologist shortfall.
Projections by a peer-reviewed brief estimate that only about 54.5% of psychologist demand will be met, with the 1.0 FTE psychologist count falling from 115,270 to 94,890. A secondary summary of federal projections reports a status-quo shortfall of 99,840 psychologists. These are forecasts from models.
Confidence: Medium -
5
Local access can be far worse than national averages.
A news report states one Herefordshire and Worcestershire trust reported a longest wait of 1,160 days, and over 41% of patients at one trust waited more than 90 days for a first appointment. This is a single-trust, news-based report and cannot be generalised.
Confidence: Qualitative
1Industry definition and scope
This report covers clinical psychology and psychotherapy: psychological assessment and talking-based or structured treatments delivered to people with mental health conditions, mainly depression and anxiety disorders, by trained psychologists and by other clinicians and counselors. Psychotherapy is also delivered by psychiatrists and nurses in some systems, so workforce counts for psychologists do not capture all psychotherapy provision 6.
The geographic scope is mixed. Prevalence is global 12. Access and outcome data are from England 789. Workforce projections are from the United States 345. Provider mix evidence is from mainland China 6. These sources use different definitions, periods and units, so they are compared for direction and scale, not combined into one measure.
Terminology needs care. Workforce shortfalls are counted in full-time equivalent (FTE) practitioners, while access is measured as referrals and waiting times, and outcomes as the share of patients with reliable improvement. The pack does not cover private practices, digital platforms or commercial suppliers in detail, so the scope is limited to public and professional service delivery.
Scope was set by the sources in the pack. Where a segment such as private practice had no verified data, it is described as a gap rather than estimated.
Assumptions behind these figures
- Prevalence figures are WHO estimates and are not market sizes.
2Market size, structure and value chain
The pack contains no verified global market size, revenue or spending figure for clinical psychology and psychotherapy services, so market size and growth cannot be estimated from it. The reader should treat any commercial sizing as outside this evidence base.
Demand volume is visible in NHS Talking Therapies activity. Services received 132,762 new referrals in the reported August 7 and recorded a 12-month rolling total of 671,644 courses of treatment to December 8. These are observed service volumes, not revenue. Referral volume shows the entry point of the care pathway, and courses show throughput.
The value chain in this evidence base runs from detection and referral, through assessment and waiting, to psychological treatment, with workforce supply and public funding as constraints. Funding models, price points and supplier structures for psychotherapy were not verified, so the pack cannot show how revenue flows between payers and providers. Key stakeholders visible in the sources are the WHO as a global standard setter 12, NHS England as the reporting body for talking therapies 789, and US workforce modelers and professional bodies as sources of projections 34.
- NHS Talking Therapies new referrals 132,762referrals per month Observed England, Latest available data (August) [7]
- NHS Talking Therapies courses of treatment 671,644courses (12-month rolling total) Observed England, Latest available data (12 months to December) [8]
No revenue or market share estimates are given because the pack contains no verified figures for them.
Assumptions behind these figures
- Referral and course counts are activity measures and are not converted into spending.
3Customers, demand and adoption
The main end users are adults with depression or anxiety. WHO estimates that about 5.2% of adults globally have depression, and depression is about 1.5 times more common among women 1. WHO also reports that anxiety disorders are the most common mental disorders, affecting an estimated 470 million people 2. Generalized anxiety disorder and panic disorder are priority conditions under WHO's mhGAP Program 2.
Demand is shaped by referral and access. In England, most patients who completed a course had been seen quickly: 89.7% waited less than 6 weeks in the reported August 7, against a target of 75% for referrals accessing services within 6 weeks and 95% within 18 weeks 9. Patient purchasing criteria in the sense of price or choice are not in the pack. Waiting time and clinical improvement are the main measurable criteria available.
Barriers appear mainly as access constraints. A vendor report states that about 40% of the US population, roughly 137 million people, lives in a Mental Health Professional Shortage Area 5. The same vendor report states that six in 10 psychologists were not accepting new patients 5. Because this is a vendor claim and its method is not described in the pack, it should be treated as indicative only. The pack has no verified data on patient preferences, switching behavior or digital adoption by patients.
Changing expectations are not documented in the pack. The evidence shows the demand side in volume and access terms, but not in terms of patient experience or satisfaction.
- Adults with depression worldwide 5.2percent of adults Observed Global, Latest available data [1]
- People with anxiety disorders worldwide 470million people Observed Global, Latest available data [2]
Percentages are referral shares, not patient counts. The 6-week measure covers referrals finishing a course, so it does not show waiting for patients who have not yet started.
Assumptions behind these figures
- Chart compares the target and two monthly results from different releases, so it shows direction, not trend.
4Competitive landscape and key players
The pack does not verify a supplier landscape, market shares or private-provider counts for psychotherapy. Comparison is therefore between provider models, not companies. The evidence covers three models: publicly funded national talking therapy services in England, individually based psychologist practice in the United States, and hospital-based psychotherapy provision in mainland China.
In England, NHS Talking Therapies is a structured public service with national reporting. It is measured against a 6-week and 18-week access target 9 and publishes monthly performance and outcome data 78. Its strength is transparent national reporting. Its limits are local variation in waiting times, which one trust case illustrates 10.
In the United States, the shortage data describe individually practiced psychologists and counselors. The vendor report states six in 10 psychologists were not accepting new patients 5. This suggests a capacity constraint in independent practice, but the pack does not compare private and public pricing or quality.
In mainland China, a cross-sectional study found that psychiatrists (39.1%) and nurses (38.9%) were the main psychotherapy providers in psychiatric hospitals, while clinical psychologists made up 6.9% and counselors 5.0% of psychotherapy providers across mental health sectors 6. This shows a hospital-based model where psychotherapy is delivered mainly by non-psychologist staff. The study is from an earlier period and reflects one country's system.
Concentration and competitive pressure cannot be measured from the pack. The three models are not directly comparable on cost, quality or pricing, and the pack contains no verified cost per treated patient.
No company rankings or market share claims are made. Vendor claims are identified as such.
Assumptions behind these figures
- Provider model descriptions are drawn from the study design and reported figures only.
5Technology, operations and workforce
Workforce capacity is the main operational constraint in the evidence. A peer-reviewed brief projects that the number of 1.0 FTE psychologists will decline from 115,270 to 94,890 and that only about 54.5% of psychologist demand will be met 4. A secondary summary of federal workforce projections reports status-quo shortfalls of 99,840 psychologists and 99,780 mental health counselors 3. These are model forecasts, and the primary federal release was not retrieved directly.
The table sets out the workforce indicators available in the pack. Rows drawn from other sources are marked with their source identifiers.
Technology and digital health are not verified in this pack. No primary evidence was retrieved on digital psychotherapy platforms, their clinical outcomes, or their operational effect on waiting times. Any statement about digital delivery in this report is therefore an open question, not a finding.
Established practice versus emerging approaches cannot be separated from the pack. Structured talking therapies are the core of NHS Talking Therapies 7, which makes them established within that service. Newer approaches are not covered. Productivity and skills data are also missing, as is evidence on the training pipeline for psychologists.
| Indicator | Value | Value type | Source |
|---|---|---|---|
| Projected psychologist shortfall | 99,840 FTE | Forecast | S3 |
| Projected mental health counselor shortfall | 99,780 FTE | Forecast | S3 |
| Projected 1.0 FTE psychologists, from current to projected count | 115,270 to 94,890 | Forecast | S4 |
| Share of psychologist demand projected to be met | 54.5% | Forecast | S4 |
| Psychologists not accepting new patients | 60% | Observed (vendor claim) | S5 |
Workforce forecasts are model outputs. They are shown as indicators of direction, not as definitive counts.
Assumptions behind these figures
- Projections assume status-quo conditions as described in the sources.
- Shortfall figures from S3 and S4 use different model bases and are not additive.
6Regulation, standards, risk and sustainability
The main jurisdiction in the access data is England. The pack does not identify the binding rules governing NHS Talking Therapies, such as statutory service specifications or licensing of practitioners. It also does not retrieve NICE guidance or other evidence-based treatment standards, so the regulatory and clinical standards that apply in England cannot be verified from this pack. Readers should consult the relevant regulator and guidance directly.
In the United States, the workforce figures are projections from modeling, not regulatory requirements 34. The pack does not identify binding licensing or reimbursement rules. WHO's mhGAP Program is a global program that prioritizes certain conditions 2. It is a guidance framework for health systems, not a binding national rule in any jurisdiction covered here.
Privacy and individual safety are relevant to any patient-level data. This report uses only aggregated service and prevalence data and does not give advice about individual patients or treatment choices. Operational risks visible in the pack include waiting times, workforce shortages and declining reported outcomes 7810.
Environmental and social sustainability factors are not covered by the sources. Equity by ethnicity, income or rurality for psychotherapy access in England was not verified, which is a material gap given the single-trust waiting evidence 10.
This section is not legal or clinical advice. Binding requirements and voluntary guidance are not separated in the pack and should be verified with the relevant authority.
Assumptions behind these figures
- The pack's statements on regulation are limited to what the sources say. No legal interpretation is given.
7Challenges, opportunities and case examples
The main challenge is uneven access. England's national 6-week measure is above target in the latest releases: 91.0% in January and 89.7% in August 97. Yet one Herefordshire and Worcestershire trust reported a longest wait of 1,160 days, and over 41% of patients at one trust waited more than 90 days for a first appointment 10. A national average can hide severe local delays, and the news report is a single-trust example.
A second challenge is outcomes. NHS England reports that 66.9% of patients achieved reliable improvement in the reported December figure and that outcomes fell 8. The pack does not give the earlier baseline, and it is not clear whether the fall reflects case mix, measurement or service pressure. The data cannot establish cause.
The chart shows the gap between the target and the reported results. The target is a floor, not a ceiling, so the gap indicates that the national target was being met while the outcome measure moved in the other direction.
Opportunities identified in the evidence are workforce expansion, more efficient use of existing capacity and better local monitoring. Digital delivery may help, but the pack does not provide verified evidence of its effect. The case examples are the national NHS Talking Therapies service in England 789, the single trust example 10 and the hospital-based psychotherapy model in mainland China 6. Comparable market examples were limited in the pack.
The trust example comes from a news and analysis source. It is used as an illustration of variation, not as a representative measure.
Assumptions behind these figures
- Waiting-time comparisons assume the national and trust measures use compatible definitions, which the sources do not confirm.
8Outlook and strategic implications
In the near term, the evidence points to continued pressure on access in places where workforce capacity is limited. Forecasts from the United States project that a sizeable shortfall will persist under status-quo conditions 34. These are scenario projections, not observed outcomes, and their precision is limited by modeling assumptions.
In England, the evidence is mixed. National access targets were met in the latest releases 79, but reported outcomes fell 8 and local waiting times can be very long 10. The most likely shift, based only on the pack, is greater focus on local variation and outcome monitoring, but the pack does not contain forward forecasts for England.
Practical implications differ by stakeholder. Public commissioners and service leaders should monitor local waits and outcomes alongside national averages. Workforce planners should treat FTE shortfalls as a planning signal and verify them against primary federal data. Providers and suppliers should not assume market demand can be sized from this evidence, because revenue and price data are missing. Researchers should close the gaps on private provision, digital outcomes and equity, which are the most important unknowns.
This outlook is general industry analysis. It is not individual medical advice and does not recommend clinical decisions.
Assumptions behind these figures
- Scenarios are qualitative, based only on the sources in the pack.
- No market growth rate is assumed.
9Conclusion
Demand for clinical psychology and psychotherapy is large and well documented, but the pack supports only a limited view of supply, access and outcomes. England's national access measures look favorable, while outcome decline and long local waits point to a more uneven picture. The most defensible takeaways are that workforce capacity is the central constraint and that commercial sizing requires data the pack does not contain.
How this was built
This report draws only on the ten sources in the pack. It mixes global, English and US evidence, plus one Chinese study, and does not combine them into a single measure. Forecasts, vendor claims and news reports are labeled as such. No market size or revenue figures are used because none were verified.
Limits to keep in mind
- No verified global market size, revenue or spending figures for clinical psychology and psychotherapy services were retrieved.
- No verified cost per treated patient or private-versus-public price comparison was retrieved. The primary US federal workforce release was not retrieved directly.
- The most recent NHS England outcome figure was not verified. The 66.9% figure is for the reported December period, and no earlier baseline was retrieved.
- Private-sector provider counts, market share and supplier landscape were not verified.
- Digital mental health adoption and outcome evidence for psychotherapy platforms was not verified from primary sources.
- Equity data by ethnicity, income or rurality for England was not verified.
Sources
-
1
Depressive disorder (depression) fact sheet
who.int -
2
Anxiety disorders fact sheet
who.int -
3
Mental Health Workforce Shortage: The Projections to the latest projection year (citing HRSA workforce model)
mhstats.org -
4
Psychology Workforce: National and Regional Shortfalls
researchgate.net -
5
Mental Health Practice Statistics, State of the Industry (latest edition)
clinicmind.com -
6
Workforce situation of the Chinese mental health care system: results from a cross-sectional study
ncbi.nlm.nih.gov -
7
NHS Talking Therapies Monthly Statistics, Performance August (latest release): Introduction
digital.nhs.uk -
8
Monthly operational statistics, February (latest release)
england.nhs.uk -
9
NHS Talking Therapies Monthly Statistics, Performance January (latest release): Waiting Times
digital.nhs.uk -
10
People are waiting over three years for NHS talking therapies
madintheuk.com